Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA-seq03:21

RNA-seq

10.4K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
10.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical implications of RAS mutations in AML: prognostic significance is based upon the involved gene and mutation complexity.

Blood advances·2026
Same author

Characterization of Genetic Etiologic Factors for Pediatric Acute Lymphoblastic Leukemia in Large Childhood Cancer Survivorship Cohorts.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

High-resolution single-cell mapping of clonal hematopoiesis and structural variation in aplastic anemia.

Nature genetics·2026
Same author

IRS4 is a PI3K-activating cancer dependency up-regulated through DNA rearrangements or epigenetic mechanisms in multiple solid tumors.

Science advances·2026
Same author

Cancer Treatment-Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Therapy-related mutational signatures in subsequent neoplasms among survivors of childhood cancer.

Cancer discovery·2026

Related Experiment Video

Updated: Sep 9, 2025

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations
11:52

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations

Published on: August 4, 2016

10.4K

CanID: a robust and accurate RNAseq Expression-based diagnostic classification scheme for pediatric malignancies.

Daniel K Putnam, Alexander M Gout, Delaram Rahbarinia

    Biorxiv : the Preprint Server for Biology
    |September 2, 2025
    PubMed
    Summary
    This summary is machine-generated.

    A new machine learning model, Cancer Identification (CanID), accurately classifies pediatric cancer subtypes using only gene expression data. This tool enhances tumor diagnosis and stratification for precision therapy.

    More Related Videos

    Rare Event Detection Using Error-corrected DNA and RNA Sequencing
    10:36

    Rare Event Detection Using Error-corrected DNA and RNA Sequencing

    Published on: August 3, 2018

    12.2K
    Identification of Key Factors Regulating Self-renewal and Differentiation in EML Hematopoietic Precursor Cells by RNA-sequencing Analysis
    12:44

    Identification of Key Factors Regulating Self-renewal and Differentiation in EML Hematopoietic Precursor Cells by RNA-sequencing Analysis

    Published on: November 11, 2014

    12.4K

    Related Experiment Videos

    Last Updated: Sep 9, 2025

    Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations
    11:52

    Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations

    Published on: August 4, 2016

    10.4K
    Rare Event Detection Using Error-corrected DNA and RNA Sequencing
    10:36

    Rare Event Detection Using Error-corrected DNA and RNA Sequencing

    Published on: August 3, 2018

    12.2K
    Identification of Key Factors Regulating Self-renewal and Differentiation in EML Hematopoietic Precursor Cells by RNA-sequencing Analysis
    12:44

    Identification of Key Factors Regulating Self-renewal and Differentiation in EML Hematopoietic Precursor Cells by RNA-sequencing Analysis

    Published on: November 11, 2014

    12.4K

    Area of Science:

    • Oncology
    • Bioinformatics
    • Machine Learning

    Background:

    • Pediatric cancer subtype classification is crucial for targeted therapies.
    • Current methods face challenges in scope, precision, and standardization for pediatric cancers.
    • Omics-based machine learning classifiers are increasingly used to augment histopathology.

    Purpose of the Study:

    • To develop a robust machine learning classification scheme for pediatric cancer subtypes.
    • To address analytical challenges in classifying diverse pediatric solid tumors and hematologic malignancies.
    • To provide a transcriptome-based approach for improved tumor diagnosis and stratification.

    Main Methods:

    • Developed Cancer Identification (CanID), a stacked ensemble machine learning model.
    • Utilized gene-level RNA sequencing count data (transcriptomic features) as the sole input.
    • Trained CanID on 3203 pediatric cancer samples across 13 solid tumor and 38 hematologic malignancy subtypes.

    Main Results:

    • Achieved 99% accuracy for solid tumors and 92-93% accuracy for hematologic malignancies on independent test datasets.
    • Demonstrated robustness against biological and technical variations, including data collection differences and class imbalance.
    • Successfully classified challenging subtypes that are difficult for clinical histology evaluation.

    Conclusions:

    • CanID offers a highly accurate and robust transcriptome-based classification scheme for pediatric cancers.
    • The model's biological interpretability aids in advancing tumor diagnosis and stratification.
    • CanID represents a valuable tool for precision oncology and clinical decision-making.